Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 27Terminated 13Active not recruiting 10Completed 6Withdrawn 2Unknown 2Suspended 2Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Plasma cell 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 21Recurrence 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia, Lymphocytic, Chronic, B-Cell 2Neoplasm, Residual 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Hematologic Neoplasms 1Graft vs Host Disease 1Burkitt Lymphoma 1

Interventions

Azacitidine 10Decitabine 9Cyclophosphamide 9Cytarabine 7Tacrolimus 6Antilymphocyte Serum 6fludarabine phosphate 5Mycophenolic Acid 5Melphalan 5Busulfan 5fludarabine 4Whole-Body Irradiation 4Peripheral Blood Stem Cell Transplantation 4Idarubicin 4Rituximab 3Polymerase Chain Reaction 3Lenalidomide 3Filgrastim 3venetoclax 2sargramostim 2Tretinoin 2Radiotherapy 2Methylprednisolone 2Methotrexate 2Flow Cytometry 2Etoposide 2Cyclosporine 2Cord Blood Stem Cell Transplantation 2Clofarabine 2Blood Specimen Collection 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Myelodysplastic Syndromes × venetoclax × Clear all
NCT05005299 2023-08-01

VICTORY

Melbourne Health

Phase 1 Unknown
18 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01211457 2019-07-16

Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)

Cyclacel Pharmaceuticals, Inc.

Phase 1/2 Unknown
65 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡